0.98% 0.0387

Lumos Pharma Inc (LUMO)

Lumos Pharma Inc (LUMO) 最新ニュース

Lumos Pharma Inc (LUMO)

Lumos Pharma Inc (LUMO) 最新ニュース

AEON Biopharma (AMEX:AEON) Stock Quotes, Forecast and News Summary - Benzinga

Selling Buzz: Lumos Pharma Inc [LUMO] Chief Scientific Officer McKew John C. sells 3,407 shares of the company - Knox Daily

Taking a look at what insiders are doing to gauge the Aadi Bioscience Inc (AADI)’s direction - Knox Daily

Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024 - StockTitan

Atlantic Union Bankshares Corp [AUB] Records 50-Day SMA of $37.13 - Knox Daily

The growth track for Lumos Pharma Inc (LUMO) has changed recently - SETE News

Lumos Pharma Inc (LUMO) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

A preview of the September Tech issue of Contemporary Pediatrics - Contemporary Pediatrics

Lumos Diagnostics Holdings Full Year 2024 Earnings: US$0.018 loss per share (vs US$0.038 loss in FY 2023) - Yahoo Finance

A company insider recently sold 3,407 shares of Lumos Pharma Inc [LUMO]. Should You also Consider to Sale? - Knox Daily

Lumos Adds Prominent Security Industry Veterans to Board, Leadership Team - Yahoo Finance

Lumos Pharma to Participate in World Orphan Drug Congress USA - GuruFocus.com

Uncovering the Potential of Lumos Pharma Inc (LUMO) Stock - The InvestChronicle

Reviewing Lumos Pharma (NASDAQ:LUMO) & Korro Bio (NASDAQ:KRRO) - Defense World

Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Brokers Issue Forecasts for Lumos Pharma, Inc.’s FY2024 Earnings (NASDAQ:LUMO) - Defense World

FY2024 EPS Estimates for SIGA Technologies, Inc. Cut by Analyst (NASDAQ:SIGA) - Defense World

MAG Silver Corp. (NYSEAMERICAN:MAG) to Post FY2024 Earnings of $0.79 Per Share, Stifel Canada Forecasts - Defense World

LGI Homes, Inc. (NASDAQ:LGIH) Forecasted to Earn FY2024 Earnings of $9.10 Per Share - Defense World

Lumos Pharma (NASDAQ:LUMO) PT Lowered to $13.00 at Oppenheimer - Defense World

Lumos Pharma Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Lumos Pharma, Inc. (NASDAQ:LUMO) Q2 2024 Earnings Call Transcript - Insider Monkey

Lumos: Q2 Earnings Snapshot - The Washington Post

Lumos: Q2 Earnings Snapshot - San Francisco Chronicle

Lumos Pharma, Inc. (LUMO) Q2 2024 Earnings Call Transcript - Seeking Alpha

Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update - wallstreet:online

Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update - ForexTV.com

Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update - StockTitan

Lumos Pharma (LUMO) to Release Earnings on Thursday - Defense World

True Nature (OTCMKTS:TNTY) Stock Passes Below 200 Day Moving Average of $0.29 - Defense World

BNP Paribas Financial Markets Has $307,000 Holdings in Stitch Fix, Inc. (NASDAQ:SFIX) - Defense World

NBT Bancorp Inc. (NASDAQ:NBTB) Shares Acquired by Russell Investments Group Ltd. - Defense World

Janney Montgomery Scott LLC Grows Holdings in FormFactor, Inc. (NASDAQ:FORM) - Defense World

Marinus Pharmaceuticals (NASDAQ:MRNS) Shares Cross Below 200 Day Moving Average of $5.34 - Defense World

Silvaco Group, Inc. (NASDAQ:SVCO) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Proto Labs, Inc. (NYSE:PRLB) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Passes Below 200 Day Moving Average of $2.58 - Defense World

Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 - StockTitan

Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 - ForexTV.com

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Quotes, Forecast and News Summary - Benzinga

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Average Rating of “Buy” by Brokerages - Defense World

Enova International, Inc. (NYSE:ENVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Avino Silver & Gold Mines (NYSE:ASM) Shares Down 7.6% - Defense World

Great-West Lifeco Inc. (TSE:GWO) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

MidWestOne Financial Group (MOFG) Scheduled to Post Earnings on Thursday - Defense World

FirstService (TSE:FSV) Share Price Crosses Above 200-Day Moving Average of $214.46 - Defense World

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Rating of “Buy” from Analysts - Defense World

Lumos Pharma Reports Full Year 2021 Financial Results and Announces Plan to Perform Interim Analyses of OraGrowtH Trials - Barchart

Austin's life sciences sector is booming — can it catch up to other top U.S. hubs? - The Business Journals

Down 16.1% in 4 Weeks, Here's Why Lumos (LUMO) Looks Ripe for a Turnaround - Yahoo New Zealand News

Blackstone Inc. Lowers Position in Lumos Pharma, Inc. (NASDAQ:LUMO) - Defense World

Lumos Pharma (NASDAQ:LUMO) Trading Down 2.8% - Defense World

Lumos Pharma Announces Governance Decisions and Trial UpdatesTipRanks.com - TipRanks

Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024 - Yahoo Finance

Lumos Pharma (LUMO) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Movies UK

Lumos Pharma Inc (LUMO)'s Market Momentum: Closing Strong at 2.45, Down -1.96 – DWinneX - The Dwinnex

We're A Little Worried About Lumos Pharma's (NASDAQ:LUMO) Cash Burn Rate - Simply Wall St

Lumos Secures $35M Series B Funding to Unify the SaaS and Identity Management Industries - Yahoo Finance

Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024 - ForexTV.com

Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024 - WDRB

Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024 - GlobeNewswire Inc.

FY2024 EPS Estimates for Lumos Pharma, Inc. (NASDAQ:LUMO) Increased by Analyst - Defense World

Daniel Farb Buys 22% More Lumos Pharma Shares \ - Yahoo Lifestyle UK

Lumos Pharma, Inc. (NASDAQ:LUMO) Q1 2024 Earnings Call Transcript - Insider Monkey

Lumos Pharma (LUMO) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Movies UK

Earnings call: Lumos Pharma gears up for Phase 3 trial of LUM-201 By Investing.com - Investing.com Canada

Earnings call: Lumos Pharma gears up for Phase 3 trial of LUM-201 By Investing.com - Investing.com

Lumos Pharma maintains shares price target, Outperform rating on LUM-201 potential - Investing.com Canada

LUMOに似た銘柄